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Thymic stromal lymphopoietin (TSLP) is a four-helix bundle cytokine that plays a critical role in the regulation of immune
responses and in the differentiation of hematopoietic cells. TSLP signals through a heterodimeric receptor complex consisting
of an interleukin-7 receptor a chain and a unique TSLP receptor (TSLPR) [also known as cytokine receptor-like factor 2
(CRLF2)]. Cellular targets of TSLP include dendritic cells, B cells, mast cells, regulatory T (Treg) cells and CD4+ and CD8+ T
cells. The TSLP/TSLPR axis can activate multiple signaling transduction pathways including the JAK/STAT pathway and the
PI-3 kinase pathway. Aberrant TSLP/TSLPR signaling has been associated with a variety of human diseases including asthma,
atopic dermatitis, nasal polyposis, inflammatory bowel disease, eosinophilic eosophagitis and, most recently, acute lympho-
blastic leukemia. A centralized resource of the TSLP signaling pathway cataloging signaling events is not yet available. In
this study, we present a literature-annotated resource of reactions in the TSLP signaling pathway. This pathway map is pub-
licly available through NetPath (http://www.netpath.org/), an open access signal transduction pathway resource developed
previously by our group. This map includes 236 molecules and 252 reactions that are involved in TSLP/TSLPR signaling path-
way. We expect that the TSLP signaling pathway map will provide a rich resource to study the biology of this important
cytokine as well as to identify novel therapeutic targets for diseases associated with dysregulated TSLP/TSLPR signaling.
Database URL: http://www.netpath.org/pathways?path_id=NetPath_24
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Introduction
Thymic stromal lymphopoietin (TSLP) is a type I cytokine that
belongs to the interleukin-2 cytokine family. TSLP signaling
requires a heterodimeric receptor complex composed of
interleukin-7 receptor a chain (Gene Symbol, IL7R) and
the TSLP receptor subunit (TSLPR; Gene Symbol, CRLF2),
which is similar to the common g chain (1, 2). TSLP was first
identified from the conditioned medium of the murine
thymic stromal cell line, Z210R.1, as a growth factor that
supported B lymphopoiesis in vitro (3, 4). TSLP is widely
expressed in vivo including epithelial cells of the lung,
skin and gut, Hassall’s corpuscles in the thymic medulla,
mucosa-associated lymphoid tissues and tonsils. TSLP is also
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expressed by primary skin keratinocytes, smoothmuscle cells
and lung fibroblasts (5–7). At the organ level, it has been
shown that heart, liver, spleen and prostate have higher
expression levels of TSLP compared with lung, skeletal
muscle, kidney, spleen, ovary, small intestine and colon (8).
TSLP can execute its biological functions through its
action on many different types of cells. TSLP can activate
CD4+ T cells (9) and CD8+ T cells in mice (10) and induces
B-cell proliferation and differentiation in humans (11). It
also enhances maturation and proliferation of dendritic
cells and naive T-cells, respectively. It has also been shown
to induce the release of T-cell attracting chemokines from
monocytes. In combination with interleukin-1 and tumor
necrosis factor, TSLP can stimulate the production of Th2
cytokines by human mast cells (12).
On binding its receptor complex, TSLP can activate mul-
tiple signal transduction pathways. Previously, studies have
shown that stimulation of IL7R/TSLPR complex by TSLP in-
duces the phosphorylation and activation of Janus kinases
(JAKs). Activated JAKs, in turn, regulate the activity of
signal transducers and activators of transcription (STAT)
factors, which include STAT1, STAT3, STAT4, STAT5a,
STAT5b and STAT6 (13–15). In addition, several other pro-
teins such as AKT1, ERK1/2, JNKs, ribosomal protein S6
kinase and 4E-BP1 have also been shown to be activated
on TSLP stimulation (10, 13, 16, 17). Recently, our group
carried out SILAC-based quantitative phosphoproteomic
analysis to identify molecules that are differentially phos-
phorylated on stimulation with TSLP. Our results revealed
that TSLP can regulate phosphorylation of 226 proteins
including several members of the SRC and TEC family of
kinases and protein phosphatases such as PTPN6 (Protein
tyrosine phosphatase non-receptor type 6, also called
SHP-1) and PTPN11 (Protein tyrosine phosphatase non-
receptor type 11, also called SHP-2) (18).
TSLP and TSLPR have been implicated in a number of
pathological conditions. TSLP expression was found to be
increased in asthmatic airways and its overexpression corre-
lated with severity of disease (19, 20). TSLP was reported to
be upregulated in keratinocytes of atopic dermatitis pa-
tients (21). Overexpression of TSLP has been shown to be
associated with the development of nasal polyps (22). TSLP
has also been implicated in the regulation of intestinal im-
munity and inflammation in a mouse model of inflamma-
tory bowel disease (23). Rothenberg and colleagues have
reported that TSLP is the most likely candidate gene
responsible for pathogenesis of eosinophilic esophagitis
(24). Several studies also show the involvement of the
TSLPR gene in leukemia (25–30). Yoda and colleagues have
shown that high expression of TSLPR results from transloca-
tion of the immunoglobin heavy chain locus or interstitial
genomic deletions in B-cell acute lymphoblastic leukemia
(31). An activating mutation in TSLPR, Phe232Cys, has also
been found to be associated with this leukemia (31, 32).
Despite the importance of the TSLP signaling pathway,
the reactions specific to TSLP signaling reported to date are
not available in any public pathway resource. Kyoto
Encyclopedia of Genes and Genomes (KEGG) database
(33) contains pathways through several cytokine receptors
including receptors for TSLP; however, KEGG represents
generic signaling modules that are restricted to JAK-STAT,
RAS-RAF-MAPK and PI3K-AKT and does not have a path-
way that is specific to TSLP signaling. Even these generic
signaling modules in KEGG contain only 25 molecules and
30 reactions, without any link to corresponding research
articles. Our catalog contains 236 molecules and 252 reac-
tions stimulated by TSLP through literature search and
manual annotation, which is made available through
NetPath (34) (http://www.netpath.org/pathways?path_id=
NetPath_24). NetPath is an open access signaling pathway
resource that provides a list of all of the reactions curated
from the literature to present a comprehensive and global
view of signaling pathways. We have also generated a
high-confidence list and visualization of TSLP pathway
that is available through NetSlim (35) (http://www.net
path.org/netslim/NetSlim_24). NetSlim uses predefined cri-
teria to show only high-confidence reactions as a means to
generate a ‘slim’ version of the pathway, which is less com-
plex and more easily visualized.
Annotation of TSLP signaling
pathway reactions
An extensive search of published literature was carried out
in PubMed to annotate reactions involved in the TSLP sig-
naling pathway. The query terms used are listed in the
Appendix. Research articles were screened for information
about reactions such as protein–protein interactions (PPIs),
posttranslational modifications (PTMs), translocation and
activation/inhibition of proteins, which occur on stimula-
tion with TSLP. We also looked for genes that are differen-
tially regulated on stimulation by TSLP in humans. The
reactions stimulated by TSLP as compared with an unstimu-
lated state (reactions induced on co-stimulation with TSLP
and any other stimuli were excluded) in human or other
mammalian systems were included. We used PathBuilder
(36), a pathway annotation tool developed by our group,
to annotate reactions in TSLP signaling. Reactions were cap-
tured under the following categories:
Protein–protein interactions
Proteins interact with other proteins and nonproteins and
mediate transduction of extracellular signals into the inter-
ior of the cell. Physical association events between proteins
that occur on TSLP stimulation were captured under this
category. These were classified as either ‘binary’ or
.............................................................................................................................................................................................................................................................................................
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‘complex’ (multimeric) associations. The PPIs induced by
TSLP were considered ‘binary’ if homomeric/heteromeric
interactions are reported between two proteins or if only
two proteins are studied/identified in coprecipitation
assays. Multimeric association of proteins consisting more
than two components was considered as ‘complex’ inter-
actions. For example, biochemical interaction between
TSLP and IL-7 receptor alpha subunit and TSLPR has been
reported by several groups (2). More recently, Zhong et al.
(18) have shown that TSLP can induce the interaction be-
tween SHP-2 and GAB2 (GRB2-associated binding protein
2). Such PPI events have been annotated with a link to
the corresponding references.
Enzyme–substrate reactions
PTMs are dynamic covalent modifications on proteins. PTMs
are important for regulation and integration of cellular sig-
naling events. PTMs regulate PPIs, activity of enzymes and
the cellular localization of proteins. Under this category, we
have annotated enzyme-catalyzed reactions that have been
reported to be stimulated by TSLP. Like other cytokines,
TSLP also uses the JAK-STAT signaling module to transmit
signals in cells by inducing phosphorylation of some mem-
bers in the module, including JAK1, JAK2, STAT1, STAT3,
STAT4, STAT5A, STAT5B and STAT6 (13–15, 37, 38). Apart
from the JAK-STAT signaling module, TSLP also induces ac-
tivation of the PI3K-AKT-mTORC1 (10, 13, 16, 39–41), SRC/
TEC (42), ERK (13, 17, 40, 41, 43), NFkB (13), JNK1/2 (17) and
p38MAPK (17) signaling modules in diverse cell types. More
recently, a quantitative phosphoproteomics study carried
out by our group revealed TSLP-induced changes in phos-
phorylation status of 226 molecules (18). Among them, ca-
talysis events for which the immediate upstream enzyme is
proven in the study were classified as ‘direct’ reactions.
Reactions for which the upstream enzyme is not proven
in the study were classified as ‘induced’ catalysis events.
The site and residue of the PTM was also captured when
available.
Protein translocation events
Movement of proteins across subcellular compartments is
critical for the function of the proteins as well as for the
transfer of information inside the cell. These translocation
events may depend on a variety of factors, which include
PTMs or association/dissociation with other molecules. For
example, TSLP signaling in dendritic cells also leads to acti-
vation and nuclear transport of NFkB1, NFkB2, RELA and
RELB proteins to induce the production of OX40L (13). The
proteins that undergo translocation on the stimulation of
TSLP were listed in this category. The source and target
cellular compartments of the translocated proteins were
also documented.
Activation/inhibition reactions
Activation and inhibition of proteins, at the human inter-
face, are identified by activity assays. This category lists pro-
teins whose activity is found to be altered on TSLP
treatment. When the activity of proteins has been shown
to be changed by TSLP stimulation through activation/inhib-
ition assays, such as using small kinase inhibitors or through
the use of intrinsic or extrinsic substrates, these proteins
were included under the activation/inhibition category. For
example, the involvement of SRC and TEC family of kinases
in the TSLP induced proliferation of B cells has been demon-
strated through pharmacological inhibitors (42, 44).
Gene regulation events
Most stimuli bring about their phenotypic effects by alter-
ing the gene expression in the target cell. Under this cat-
egory, we annotated genes whose expression levels are
reported to change in response to TSLP treatment. Gene
expression changes at the mRNA level in human cells/tissues
proved using various techniques including DNA microarray
and northern blot were captured. In addition, transcrip-
tional regulators of these genes that are differentially regu-
lated were also annotated, if proven in the study. For
example, induction of STAT3 by TSLP regulates the expres-
sion of NME1 and MYC in trophoblasts and of IL6, IL8 and
CCL11 in smooth muscle cells (17, 45). In T lymphocytes,
TSLP-induced STAT5 regulates the expression of CISH and
IL2RA (45, 46).
In all the above-mentioned categories, gene symbols and
NCBI Gene identifiers were used to represent the molecules
involved in reactions. We have also documented additional
information for reactions such as (i) species of the protein(s)
and cell line/type used to prove the reaction; (ii) the cellular
compartment where the reaction takes place; (iii) the ex-
periment type, i.e. whether the reaction was carried out
in vivo or in vitro; and (iv) the PubMed identifier of the
study where the reaction was described. We have also
given a brief description for each of the reactions under
the ‘Comments’ section.
Summary of TSLP pathway
annotation
Our literature survey and annotation of articles resulted in
the identification of 236 proteins that are involved in med-
iating the effects of TSLP. These molecules were found to
be involved in 9 PPIs, 232 catalysis events, 7 translocation
events and 4 activation events. The biomedical significance
and the relatively sparse information available for this im-
portant pathway in the literature, underscore the need for
additional systematic studies required to identify the
.............................................................................................................................................................................................................................................................................................
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effectors of this pathway and their biological roles. Most
enzyme-substrate reactions that we cataloged were ‘indir-
ect’ and involve phosphorylation or dephosphorylation
events. The site and residue information of PTMs was anno-
tated for 155 proteins. We also cataloged 91 genes, which
were transcriptionally regulated on TSLP stimulation in pri-
mary human cells or cell lines. As mentioned above, these
reactions are linked to the corresponding published litera-
ture where they were described. The pathway reactions
were reviewed both internally and by an external pathway
authority to ensure availability of high-quality data to the
biomedical research community.
Data formats, availability and
visualization
The TSLP pathway webpage in the NetPath includes a de-
scription of the pathway aswell as statistics of the number of
molecules and reactions. The pathway reactions are encoded
in various community standard data exchange formats such
as Proteomics Standards Initiative for Molecular Interaction
(PSI-MI version 2.5) (47), Biological PAthway eXchange
(BioPAX level 3) (48) and Systems Biology Markup
Language (SBML version 2.1) (49). Users can download
these files from NetPath and import them in various freely
available software such as Cytoscape (50), VISIBIOweb (51)
and ChiBE (52) to visualize the pathway reactions. The data
are also available in tab delimited and Microsoft Excel for-
mats. The TSLP pathway in NetPath can also be accessed
through WikiPathways (53), another open collaborative
platform dedicated to the curation of biological pathways.
The TSLP signaling pathway map
Even though pathway reactions can be visualized and ana-
lyzed using the above-mentioned software, these do not
Figure 1. An overview of the TSLP pathway page in NetPath. The TSLP pathway page in NetPath provides statistics pertaining to
the number of molecules curated, links to TSLP pathway reactions and a list of genes that are differentially regulated by TSLP.
Each molecule in the pathway page is linked to the corresponding NetPath molecule page, which is further linked to Entrez
Gene, HPRD, OMIM and Swiss-Prot identifiers. The reaction page of the TSLP pathway contains a list of each type of reaction
such as physical interactions, enzyme catalysis or transport with a brief description of the reactions including their PTM depend-
ence or interacting regions/domains/motifs whenever available in literature. The list of curators and reviewers are provided in
the TSLP pathway page with the details of the pathway authority. A comments tab is also provided.
.............................................................................................................................................................................................................................................................................................
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give directionality to the reactions involved. Also, in many
cases the relationship among molecules is not clear or
linked to canonical signaling pathways (Figure 1). This
makes it difficult for the user to interpret the pathway.
To circumvent this problem, we have also developed a
high-confidence signaling map version of TSLP pathway.
The high-confidence reactions were filtered using the cri-
teria described previously by our group (35). The direction-
ality of molecular reactions were devised based on TSLP-
induced signaling studies (for instance from studies that
use inhibition assays) (17, 40, 54). The pathway map was
made using PathVisio, a freely available pathway drawing
software (55).
This high-confidence NetSlim pathway map contains 37
molecules involved in the TSLP/TSLPR complex signaling
system (Figure 2). Two enzyme families—SRC and TEC—
along with two enzyme complexes, PI3K and MTORC1,
have been studied in TSLP signaling through the use of
small molecule inhibitors (5, 13, 16, 44, 56). These have
been included in the high-confidence TSLP signaling map.
This pathway map is available as part of the NetSlim re-
source (35) and can be accessed at http://www.netpath.
org/netslim. These pathway data are provided in all the
exchange formats mentioned above. Apart from these,
the pathway map is also provided in .pml, GenMAPP (57),
.ng and .df formats.
Update process
The TSLP signaling pathway will be regularly updated, as
additional signaling events are reported in the literature.
The query terms in the Appendix will be used to search for
newer studies pertaining to the TSLP signaling pathway as
they are published. The pathway map will also be annually
updated based on NetSlim criteria by inclusion of further
molecules and their reactions as more studies report them
in the future. We hope that the biomedical research com-
munity will actively participate in the continuous update
and improvement of the TSLP signaling pathway resource
and map provided here.
Conclusions
Availability of TSLP signaling reactions in a single resource
will aid in understanding the role of various molecules in
the biology of this pathway. Such data can also be used to
analyze high-throughput data from various platforms
including DNA/protein microarrays and mass spectrom-
etry-based proteomics experiments. These data have been
submitted to the NetPath resource and are made available
in diverse community standard data exchange formats so
that they can be easily visualized and analyzed. We hope
that this resource will help in designing experiments aimed
at expanding the existing knowledge of the TSLP signaling
in both normal and disease physiology. We encourage
active participation of researchers to improve the quality
and content of our resource. The scientific community can
give their suggestions and comments through NetPath
(http://www.netpath.org/comments).
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Cytokine receptor-like molecule 2
Cytokine receptor-like factor 2
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